Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Type of study
Language
Year range
1.
Journal of Reproduction and Infertility. 2017; 18 (1): 205-209
in English | IMEMR | ID: emr-185156

ABSTRACT

Background: Invasive mole is responsible for most cases of localized gestational trophoblastic neoplasia. Gestational trophoblastic disease describes a number of gynecologic tumors that originate in trophoblastic layer including hydatidiform mole [complete or partial], invasive mole, choriocarcinoma, placental site trophoblastic tumor and epitheloid trophoblastic tumor. Invasive mole may arise from any pregnancy event although in most cases is diagnosed after molar pregnancy. Overall cure rate in low risk patients is nearly 100% and in high-risk patient 90%. In rare cases, molar tissue traverses thickness of myometrium and leads to perforation and acute abdomen and invasive mole infrequently metastasis. The best treatment option is chemotherapy [according to stage and score with single or multiple agent] and in patients that fertility is not the matter, hysterectomy can be done


Case Presentation: A 41 years old G3P2ab1 woman referred to Firouzgar hospital 2 months after curettage of molar pregnancy with vaginal bleeding and acute abdomen. In workup, HCG 224000 mIU/ml and evidence of metastasis was detected. Chemotherapy due to stage 3 and score 9 and surgery due to acute abdomen was done. This case was reported for its rarity


Discussion: This case reported about ovarian metastasis and uterine rupture with acute abdomen and involvement of omentum in metastatic invasive mole. Lack of surveillance led to extensive morbidity. Management of this patient was successful. In follow up, she was free of disease without sequel of any kind for five years now

2.
Journal of Reproduction and Infertility. 2016; 17 (2): 133-136
in English | IMEMR | ID: emr-178817

ABSTRACT

Background: This research was conducted to introduce a patient with rare ovarian mixed germ cell tumor, presented as molar pregnancy


Case Presentation: The patient was a 16 year old woman admitted with diagnosis of molar pregnancy. Abdominal enlargement was the only complaint. She had a large pelvic mass in physical examination. The first diagnosis was molar pregnancy due to previous ultrasonic reports and positive beta HCG. Urine pregnancy test was positive. As suction curettage was performed for her, surprisingly, the size of uterus was normal and no molar tissue was found in pathologic examination. At intraoperative ultrasound exam, an extra-uterine heterogeneous mass was found. Extra-uterine mass was confirmed by CT and MRI done after suction curettage. Mixed germ cell tumor was confirmed by histological examination after laparatomy and removing tumoral mass. Finally, she received Bleomycin, Etoposide and Cisplatin [BEP] regimen in four courses and Vincristine, Actinomycin D [Dactinomycin] and Cyclophosphamide [VAC] regimen in two courses and Diphereline for saving the other ovary


Conclusion: Some young patients misinterpret the early symptoms of an ovarian neoplasm as those of pregnancy which can lead to a delay in the diagnosis


Subject(s)
Humans , Female , Adolescent , Neoplasms, Germ Cell and Embryonal , Hydatidiform Mole , Uterine Neoplasms , Biomarkers, Tumor , Pregnancy
3.
Journal of Reproduction and Infertility. 2015; 16 (3): 174-177
in English | IMEMR | ID: emr-170168

ABSTRACT

Cervical cancer is the second most common malignancy in women worldwide. Vaginal bleeding and vaginal discharge are the most common symptoms. Although ascites has been reported in cases with cervical cancer, it is due to other causes such as ovarian metastasis. A 78-year-old diabetic woman who presented with ascites and abdominopelvic mass was misdiagnosed with ovarian cancer and treated with neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant radiotherapy. However, pathology confirmed locally advanced cervical cancer stage IV in this patient. She was discharged from the hospital three weeks after surgery with no serious complications. Considering all signs and symptoms to reach a verdict would reduce such malpractices and consequently lead to select the best management and treatment

4.
Medical Journal of the Islamic Republic of Iran. 2012; 26 (4): 185-188
in English | IMEMR | ID: emr-155648

ABSTRACT

Leydig stromal cell tumor is a rare ovarian tumor that belongs to the group of sex-cord stromal tumors. They produce testosterone leading to hyperandrogenism. We present a 41yr old woman with symptoms of virilization and a mass of right adenex via ultra Sonography, and a rise of total and free serum testosterone. An ovarian source of androgen was suspected and a surgery performed. A diagnosis of leydig-stromal cell tumor was confirmed. Our report is a reminder that although idiopathic hirsutism and other benign androgen excess disorder like Polycystic Ovarian Syndrome [PCOs] are common, ovarian mass should be considered in differential diagnosis


Subject(s)
Humans , Female , Adult , Ovarian Neoplasms , Virilism , Testosterone/blood , Sex Cord-Gonadal Stromal Tumors
SELECTION OF CITATIONS
SEARCH DETAIL